DekaBank Deutsche Girozentrale
BankPosition in JANX — Janux Therapeutics, Inc.
CIK 1456228
FRANKFURT, 2M
Position in JANX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$688,050
+$4,950 QoQ
Shares Held
49,500
0.0% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $665,183,872 across 48 Biotechnology names. JANX ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
506,457 | $226,153,308 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
211,207 | $163,186,975 | |
| 3 | BNTX |
BioNTech SE
|
481,397 | $42,786,564 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
113,193 | $37,452,167 | |
| 5 | RPRX |
Royalty Pharma plc
|
746,287 | $35,799,386 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
115,130 | $21,765,325 | |
| 7 | EXEL |
Exelixis, Inc.
|
429,690 | $18,429,403 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
280,330 | $15,835,841 |
All Filings in JANX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $688,050 | 49,500 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $683,100 | 49,500 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $1,209,780 | 49,500 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,143,450 | 49,500 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $1,336,500 | 49,500 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,650,230 | 49,500 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $2,248,785 | 49,500 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $2,073,555 | 49,500 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $1,863,675 | 49,500 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $531,135 | 49,500 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $498,960 | 49,500 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $587,565 | 49,500 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $598,950 | 49,500 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $651,915 | 49,500 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $670,230 | 49,500 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $604,395 | 49,500 | Shares | Defined | 2022-08-03 | |
| 2021-12-31 | $887,850 | 45,000 | Shares | Defined | 2022-02-02 | |
| No filing history on record for this holder in this stock. | ||||||